Perella Weinberg Partners Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-113,102	Closed	-$2.81M	–	268
2018 Q1	$2.81M	Buy	113,102 +24,934	+28%	+$606K	0.13%	138
2017 Q4	$2.14M	Buy	88,168 +6,206	+8%	+$164K	0.2%	91
2017 Q3	$2.26K	Buy	+81,962	New	+$2.19M	0.19%	98
2013 Q3	–	Sell	-444,034	Closed	-$6.34M	–	278
2013 Q2	$6.34M	Buy	+444,034	New	+$5.58M	0.43%	81

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Perella Weinberg Partners Capital Management's NXTM Position: Q2 2018 in Review

Perella Weinberg Partners Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 113,102 shares — an estimated $2.81M sold.

Perella Weinberg Partners Capital Management first reported a position in NXTM in Q2 2013 and held it in 4 quarters. The position peaked at $6.34M in Q2 2013. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

Perella Weinberg Partners Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 113,102 NxStage Medical Inc. shares in Q2 2018, an estimated $2.81M.
Perella Weinberg Partners Capital Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 4 quarters.
Perella Weinberg Partners Capital Management's NxStage Medical Inc. position peaked at $6.34M in Q2 2013.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q2 2018, filed 24 Jul 2018.